IM Cannabis Corp.

IM Cannabis Corp.

Drug Manufacturers - Specialty & Generic Healthcare Tel Aviv, Israel IMCC (NCM)

IM Cannabis Corp. engages in breeding, growing, and supply of medical cannabis products in Israel and Germany. It provides medical cannabis dried flowers; and cannabis extracts under the IMC, BLKMT, WAGNERS, and LOT420 brands. The company serves medical patients. IM Cannabis Corp. was founded in 2008 and is headquartered in Tel Aviv, Israel.

Stock Performance (90 Days)

Data through Dec 29, 2025
Price updates on page refresh. Intraday quotes available during market hours (9:30 AM - 4:00 PM EST).

Layoff History

No layoff events recorded for this company.

Recent News

Other Drug Manufacturers - Specialty & Generic Companies

View All →

Frequently Asked Questions

Has IM Cannabis Corp. had layoffs?
No layoff events have been recorded for IM Cannabis Corp. in our database. This could mean the company has not conducted significant layoffs, or any layoffs have not been publicly reported.
What industry is IM Cannabis Corp. in?
IM Cannabis Corp. operates in the Drug Manufacturers - Specialty & Generic industry, within the Healthcare sector.
Is IM Cannabis Corp. a publicly traded company?
Yes, IM Cannabis Corp. is publicly traded under the ticker symbol IMCC on the NCM. The company has a market capitalization of approximately $0.01 billion.
Where is IM Cannabis Corp. headquartered?
IM Cannabis Corp. is headquartered in Tel Aviv, Israel at Kibbutz Glil Yam, Israel.

Disclaimer

Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.

This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.

Found an error? Report it here.